Near Intelligence (NASDAQ:NIR) stock is sliding lower on Friday after the cloud-based data intelligence company released a supplement to a prospective offering.
That supplement provides several updates that the company’s investors need to know about. This includes a committee of the Board earlier this week to tackle allegations of financial mismanagement by CEO Anil Mathews and CFO Rahul Agarwa.
In addition to that, Near Intelligence notes that it determined this week that its prior financial statements shouldn’t be relied on. That includes earnings data reported in 2020, 2021 and 2022. This also includes financial data for the first two quarters of 2023. This comes as the company warns prior revenues may have been overstated.
More Trouble for NIR Stock
Investors will also remember that NIR stock is in danger of being delisted. The company isn’t compliant with Nasdaq listing standards on several accounts. That includes trading below the minimum bid price, problems with its market value of publicly held shares and issues with its market value of listed securities.
All of this is bad news for NIR stock and could continue to weigh on the company in the upcoming weeks. It’s also affecting investor morale, which helps explain why shares of NIR stock are down 19.9% as of Friday morning.
Investors looking for more of the most recent stock market news will want to keep reading!
We’re offering up all of the biggest stock market news that traders need to know about on Friday! That includes everything happening with shares of Omniq (NASDAQ:OMQS) stock, RVL Pharmaceuticals (NASDAQ:RVLP) stock and Vaccinex (NASDAQ:VCNX) stock today. You can catch up on these matters at the links below!
More Stock Market News for Friday
- Why Is Omniq (OMQS) Stock Down 43% Today?
- Why Is RVL Pharmaceuticals (RVLP) Stock Up 28% Today?
- Why Is Vaccinex (VCNX) Stock Up 26% Today?
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
